Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice

Behavioural Pharmacology

Volumn 11, Issue 3-4, 2000, Pages 279-290

  Spielewoy, C ^a   Roubert, C ^a   Hamon, M ^a   Nosten Bertrand, M ^a   Betancur, C ^a   Giros, B ^a  

^a INSERM   (France)

Author keywords

Aggressive behaviour; Antipsychotic; Circadian activity; Dopamine transporter knockout mice; Exploratory behaviour; Forced swimming test; Hyperlocomotion; Maternal behaviour; Social interaction

Indexed keywords

CLOZAPINE; DOPAMINE; DOPAMINE TRANSPORTER; HALOPERIDOL;

AGGRESSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; EXPLORATORY BEHAVIOR; FEMALE; FORCED SWIMMING TEST; KNOCKOUT MOUSE; LOCOMOTION; MALE; MATERNAL BEHAVIOR; MOUSE; NONHUMAN; SOCIAL BEHAVIOR;

EID: 0033936633     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200006000-00011     Document Type: Article

References (41)

1. Archer J (1973). Tests for emotionality in rats and mice: a review. Anim Behav 21:205-235.
2. Berlyne DE, Koenig DV, Hirota T (1966). Novelty, arousal and the reinforcement of diversive exploration in the rat. J Comp Physiol Psychol 62:222-226.
3. Bertolucci-d'Angio M, Serrano A, Driscoll P, Scatton B (1990). Involvement of mesocorticolimbic dopaminergic systems in emotional states. Prog Brain Res 85:405-416.
4. Borsini F, Volterra G, Meli A (1986). Does the behavioral 'despair' test measure 'despair'? Physiol Behav 38:385-386.
5. Bossé R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG (1997). Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19:127-138.
6. Cador M, Robbins TW, Everitt BJ, Simon H, Le Moal M, Stinus L (1991). Limbic-striatal interactions in reward-related processes: modulation by the dopaminergic system. In: The Mesolimbic Dopamine System: From Motivation to Action. Willner P, Scheel-Krüger J (editors). Cambridge: J Wiley and Sons, pp. 225-250.
7. Carlier M, Roubertoux P, Cohen-Salmon C (1982). Differences in patterns of pup care in Mus musculus domesticus. Comparisons between eleven inbred strains. Behar Neural Biol 35:205-210.
8. Carlsson A (1988). The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-186.
9. Eilman D, Golani I, Szechtman H (1989). D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements. Brain Res 26:255-267.
10. Ellenbroek BA, Cools AR (1990). Animals models with construct validity for schizophrenia. Behav Pharmacol 1:469-490.
11. Finlay JM, Zigmond MJ (1997). The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem Res 22:1387-1394.
12. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283: 397-401.
13. Geyer MA, Markou A (1995). Animal models of psychiatric disorders. In: Psychopharmacology: The Fourth Generation of Progress. Bloom FE, Kupfer DJ (editors). New York: Raven Press, pp. 787-798.
14. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
15. Hechtman L (1994). Genetic and neurobiological aspects of attention deficit hyperactive disorder: a review. J Psychiatry Neurosci 19:193-201.
16. Heilman KM (1997). The neurobiology of emotional experience. J Neuropsychiatry Clin Neurosci 9:439-448.
17. Hooks MS, Kalivas PW (1995). The role of mesoaccumbenspallidal circuitry in novelty-induced behavioral activation. Neuroscience 64:587-597.
18. Hornykiewicz O (1986). A quarter century of brain dopamine research. In: Dopaminergic Systems and their Regulation. Woodruff ON, Poat JA, Roberts PJ (editors). London: Macmillan, pp. 3-19.
19. Hughes RN (1997). Intrinsic exploration in animals: motives and measurement. Behav Process 41:213-226.
20. Inglis FM, Moghaddam B (1999). Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem 72:1088-1094.
21. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG (1998). Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Nail Acad Sci USA 95:4029-4034.
22. Jones SR, Gainetdinov RR, Hu X-T, Cooper DC, Wightman RM, White FJ, Caron MG (1999). Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci 2:649-655.
23. Kinon BJ, Lieberman JA (1996). Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124:2-34.
24. Koob GF, Nestler EJ (1997). The neurobiology of drug addiction. Neuropsychiatry Clin Neurosci 9:482-497.
25. Le Moal M (1995). Mesocorticolimbic dopaminergic neurons. In: Psychopharmacology: The Fourth Generation of Progress. Bloom FE, Kupfer DJ (editors). New York: Raven Press, pp. 283-294.
26. Meltzer HY, Matsubara S, Lee J (1989). Classification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and 5-HT2 pKi values. J Pharmacol Exp Ther 251:238-246.
27. Miczek A, Haney M (1994). Psychomotor stimulant effects of d-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice. Psychopharmacology 115:358-365.
28. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999). Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
29. Moro M, Salvador A, Simon VM (1997). Changes in the structure of the agonistic behavior of mice produced by D-amphetamine. Pharmacol Biochem Behav 56:47-54.
30. Numan M, Sheehan TP (1997). Neuroanatomical circuitry for mammalian maternal behavior. Ann NY Acad Sci 807:101-125.
31. Paulson PE, Robinson TE (1994). Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with online microdialysis. Behav Neurosci 108:624-635.
32. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979). Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201-210.
33. Puech AJ, Rioux P, Poncelet M, Brochet D, Chermat R, Simon P (1981). Pharmacological properties of new antipsychotic agents: use of animal models. Neuropharmacology 20:1279-1284.
34. Rebec GV, Grabner CP, Johnson M, Pierce RC, Bardo MT (1997). Transient increases in catecholaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience 76:707-714.
35. Robbins T, Iversen SD (1973). A dissociation of the effects of d-amphetamine on locomotor activity and exploration in rats. Psychopharmacologia 28:155-164.
36. Sams-Dodd F (1995). Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav Pharmacol 6:55-65.
37. Sams-Dodd F, Lipska BK, Weinberger DR (1997). Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology 132:303-310.
38. Sehultz W, Apicella P, Scarnati E, Ljungberg T (1992). Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci 12:4595-4606.
39. Steinpreis RE, Sokolowski JD, Papanikolaou A, Salamone JD (1994). The effects of haloperidol and clozapine on the PCP-and amphetamine-induced suppression of social behavior in the rat. Pharmacol Biochem Behav 47:579-585.
40. Walsh RN, Cummins RA (1976). The open field test: a critical review. Psychol Bull 83:482-504.
41. Wilkins A, Logan M, Kehoe P (1997). Postnatal pup brain dopamine depletion inhibits maternal behavior. Pharmacol Biochem Behav 58:867-873.